Cargando…
The Use of Massive Endoprostheses for the Treatment of Bone Metastases
Purpose. We report a series of 58 patients with metastatic bone disease treated with resection and endoprosthetic reconstruction over a five-year period at our institution. Introduction. The recent advances in adjuvant and neoadjuvant therapy in cancer treatment have resulted in improved prognosis o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920593/ https://www.ncbi.nlm.nih.gov/pubmed/17671631 http://dx.doi.org/10.1155/2007/62151 |
_version_ | 1782134207615598592 |
---|---|
author | Park, D. H. Jaiswal, P. K. Al-Hakim, W. Aston, W. J. S. Pollock, R. C. Skinner, J. A. Cannon, S. R. Briggs, T. W. R. |
author_facet | Park, D. H. Jaiswal, P. K. Al-Hakim, W. Aston, W. J. S. Pollock, R. C. Skinner, J. A. Cannon, S. R. Briggs, T. W. R. |
author_sort | Park, D. H. |
collection | PubMed |
description | Purpose. We report a series of 58 patients with metastatic bone disease treated with resection and endoprosthetic reconstruction over a five-year period at our institution. Introduction. The recent advances in adjuvant and neoadjuvant therapy in cancer treatment have resulted in improved prognosis of patients with bone metastases. Most patients who have either an actual or impending pathological fracture should have operative stabilisation or reconstruction. Endoprosthetic reconstructions are indicated in patients with extensive bone loss, failed conventional reconstructions, and selected isolated metastases. Methods and Results. We identified all patients who were diagnosed with metastatic disease to bone between 1999 and 2003. One hundred and seventy-one patients were diagnosed with bone metastases. Metastatic breast and renal cancer accounted for 84 lesions (49%). Fifty-eight patients with isolated bone metastasis to the appendicular skeleton had an endoprosthetic reconstruction. There were 28 males and 30 females. Twelve patients had an endoprosthesis in the upper extremity and 46 patients had an endoprosthesis in the lower extremity. The mean age at presentation was 62 years (24 to 88). At the time of writing, 19 patients are still alive, 34 patients have died, and 5 have been lost to follow up. Patients were followed up and evaluated using the musculoskeletal society tumour score (MSTS) and the Toronto extremity salvage score (TESS). The mean MSTS was 73% (57% to 90%) and TESS was 71% (46% to 95%). Mean follow-up was 48.2 months (range 27 to 82 months) and patients died of disease at a mean of 22 months (2 to 51 months) from surgery. Complications included 5 superficial wound infections, 1 aseptic loosening, 4 dislocations, 1 subluxation, and 1 case, where the tibial component of a prosthesis rotated requiring open repositioning. Conclusions. We conclude that endoprosthetic replacement for the treatment of isolated bone metastases is a reliable method of limb reconstruction in selected cases. It is associated with low complication and failure rates in our series, and achieves the aims of restoring function, allowing early weight bearing and alleviating pain. |
format | Text |
id | pubmed-1920593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-19205932007-08-01 The Use of Massive Endoprostheses for the Treatment of Bone Metastases Park, D. H. Jaiswal, P. K. Al-Hakim, W. Aston, W. J. S. Pollock, R. C. Skinner, J. A. Cannon, S. R. Briggs, T. W. R. Sarcoma Clinical Study Purpose. We report a series of 58 patients with metastatic bone disease treated with resection and endoprosthetic reconstruction over a five-year period at our institution. Introduction. The recent advances in adjuvant and neoadjuvant therapy in cancer treatment have resulted in improved prognosis of patients with bone metastases. Most patients who have either an actual or impending pathological fracture should have operative stabilisation or reconstruction. Endoprosthetic reconstructions are indicated in patients with extensive bone loss, failed conventional reconstructions, and selected isolated metastases. Methods and Results. We identified all patients who were diagnosed with metastatic disease to bone between 1999 and 2003. One hundred and seventy-one patients were diagnosed with bone metastases. Metastatic breast and renal cancer accounted for 84 lesions (49%). Fifty-eight patients with isolated bone metastasis to the appendicular skeleton had an endoprosthetic reconstruction. There were 28 males and 30 females. Twelve patients had an endoprosthesis in the upper extremity and 46 patients had an endoprosthesis in the lower extremity. The mean age at presentation was 62 years (24 to 88). At the time of writing, 19 patients are still alive, 34 patients have died, and 5 have been lost to follow up. Patients were followed up and evaluated using the musculoskeletal society tumour score (MSTS) and the Toronto extremity salvage score (TESS). The mean MSTS was 73% (57% to 90%) and TESS was 71% (46% to 95%). Mean follow-up was 48.2 months (range 27 to 82 months) and patients died of disease at a mean of 22 months (2 to 51 months) from surgery. Complications included 5 superficial wound infections, 1 aseptic loosening, 4 dislocations, 1 subluxation, and 1 case, where the tibial component of a prosthesis rotated requiring open repositioning. Conclusions. We conclude that endoprosthetic replacement for the treatment of isolated bone metastases is a reliable method of limb reconstruction in selected cases. It is associated with low complication and failure rates in our series, and achieves the aims of restoring function, allowing early weight bearing and alleviating pain. Hindawi Publishing Corporation 2007 2007-07-11 /pmc/articles/PMC1920593/ /pubmed/17671631 http://dx.doi.org/10.1155/2007/62151 Text en Copyright © 2007 D. H. Park et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Park, D. H. Jaiswal, P. K. Al-Hakim, W. Aston, W. J. S. Pollock, R. C. Skinner, J. A. Cannon, S. R. Briggs, T. W. R. The Use of Massive Endoprostheses for the Treatment of Bone Metastases |
title | The Use of Massive Endoprostheses for the Treatment of Bone Metastases |
title_full | The Use of Massive Endoprostheses for the Treatment of Bone Metastases |
title_fullStr | The Use of Massive Endoprostheses for the Treatment of Bone Metastases |
title_full_unstemmed | The Use of Massive Endoprostheses for the Treatment of Bone Metastases |
title_short | The Use of Massive Endoprostheses for the Treatment of Bone Metastases |
title_sort | use of massive endoprostheses for the treatment of bone metastases |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1920593/ https://www.ncbi.nlm.nih.gov/pubmed/17671631 http://dx.doi.org/10.1155/2007/62151 |
work_keys_str_mv | AT parkdh theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT jaiswalpk theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT alhakimw theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT astonwjs theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT pollockrc theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT skinnerja theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT cannonsr theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT briggstwr theuseofmassiveendoprosthesesforthetreatmentofbonemetastases AT parkdh useofmassiveendoprosthesesforthetreatmentofbonemetastases AT jaiswalpk useofmassiveendoprosthesesforthetreatmentofbonemetastases AT alhakimw useofmassiveendoprosthesesforthetreatmentofbonemetastases AT astonwjs useofmassiveendoprosthesesforthetreatmentofbonemetastases AT pollockrc useofmassiveendoprosthesesforthetreatmentofbonemetastases AT skinnerja useofmassiveendoprosthesesforthetreatmentofbonemetastases AT cannonsr useofmassiveendoprosthesesforthetreatmentofbonemetastases AT briggstwr useofmassiveendoprosthesesforthetreatmentofbonemetastases |